Autobio Diagnostics Co Ltd (603658) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.049x

Based on the latest financial reports, Autobio Diagnostics Co Ltd (603658) has a cash flow conversion efficiency ratio of 0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥435.24 Million ≈ $63.69 Million USD) by net assets (CN¥8.85 Billion ≈ $1.29 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Autobio Diagnostics Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Autobio Diagnostics Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 603658 liabilities breakdown for a breakdown of total debt and financial obligations.

Autobio Diagnostics Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Autobio Diagnostics Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Guangdong Guangzhou Daily Media Co Ltd SHE:002181	0.028x
Shareate Tools Ltd SHG:688257	0.047x
Olin Corporation NYSE:OLN	0.160x
Aerospace Hi-Tech Holding Group Co Ltd SHE:000901	0.002x
Shanghai Kingstar Winning Software SHE:300253	-0.011x
Beijing Ultrapower Software SHE:300002	0.041x
Ta Chen Stainless Pipe Co Ltd TW:2027	0.007x
Hubei Xinyangfeng Fertilizer Co Ltd SHE:000902	0.018x

Annual Cash Flow Conversion Efficiency for Autobio Diagnostics Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Autobio Diagnostics Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Autobio Diagnostics Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.69 Billion ≈ $1.27 Billion	CN¥1.31 Billion ≈ $191.59 Million	0.151x	-11.19%
2023-12-31	CN¥8.67 Billion ≈ $1.27 Billion	CN¥1.47 Billion ≈ $215.09 Million	0.170x	-13.89%
2022-12-31	CN¥7.91 Billion ≈ $1.16 Billion	CN¥1.56 Billion ≈ $228.05 Million	0.197x	-0.21%
2021-12-31	CN¥7.40 Billion ≈ $1.08 Billion	CN¥1.46 Billion ≈ $213.82 Million	0.197x	+30.67%
2020-12-31	CN¥6.59 Billion ≈ $963.64 Million	CN¥994.71 Million ≈ $145.56 Million	0.151x	-52.79%
2019-12-31	CN¥2.63 Billion ≈ $385.52 Million	CN¥842.89 Million ≈ $123.34 Million	0.320x	-3.79%
2018-12-31	CN¥1.97 Billion ≈ $287.67 Million	CN¥653.73 Million ≈ $95.66 Million	0.333x	+16.62%
2017-12-31	CN¥1.69 Billion ≈ $247.22 Million	CN¥481.73 Million ≈ $70.49 Million	0.285x	+12.80%
2016-12-31	CN¥1.64 Billion ≈ $240.70 Million	CN¥415.82 Million ≈ $60.85 Million	0.253x	-41.15%
2015-12-31	CN¥718.55 Million ≈ $105.15 Million	CN¥308.63 Million ≈ $45.16 Million	0.430x	-16.26%
2014-12-31	CN¥500.94 Million ≈ $73.30 Million	CN¥256.93 Million ≈ $37.60 Million	0.513x	+69.15%
2013-12-31	CN¥340.42 Million ≈ $49.81 Million	CN¥103.22 Million ≈ $15.10 Million	0.303x	+2.28%
2012-12-31	CN¥233.84 Million ≈ $34.22 Million	CN¥69.32 Million ≈ $10.14 Million	0.296x	-8.02%
2011-12-31	CN¥156.96 Million ≈ $22.97 Million	CN¥50.59 Million ≈ $7.40 Million	0.322x	--

About Autobio Diagnostics Co Ltd

SHG:603658 China Medical Devices

Market Cap

$2.80 Billion

CN¥19.14 Billion CNY

Market Cap Rank

#5159 Global

#1002 in China

Share Price

CN¥33.50

Change (1 day)

-1.06%

52-Week Range

CN¥32.76 - CN¥42.46

All Time High

CN¥131.73